Management Team

Management will be lead by Doventi Capital

Norton Singhavon

Founder, Chairman & CEO

Norton currently serves as the Founder and Executive Chairman of Doventi Capital. Norton has extensive experience at the senior management level of capital investments and has been involved in several large acquisitions, consolidations, and start-ups in Canada’s legal cannabis sector, both private and public. As an investor and advisor to numerous companies in Canada’s ACMPR sector, he has been responsible for internally deploying over $45 million into the legal cannabis sector and has been involved in another $65 million of public M&A ACMPR transactions.

Norton also is an advisor to, and early-stage investor in, Invictus MD (TSX.V:IMH). As an experienced corporate leader, he has facilitated in regulatory matters, corporate matters, raising capital privately and publicly, as well as strategic corporate development within the public markets.

Michael Blady

Co-Founder and Vice President

Michael formerly served as a Director of Invictus. He is also an advisor to Doventi Capital.  Michael holds degrees in Kinesiology and Geology from Simon Fraser University. As a venture capitalist, he has been involved since 2009 in the start-up and senior management of numerous public companies as well as performing the role of Consultant and Advisor. In his recent role as Director and Senior Executive of Invictus, Michael helped oversee the acquisition, management and growth of a diverse portfolio of cannabis-centric businesses owned by Invictus. These businesses include manufacturing hydroponic equipment, laboratory testing and services, cultivation, media, marketing and biopharmaceutical applications. Michael has been directly involved in raising more than $65 million of capital in the cannabis sector.

David Lynn

Chief Operating Officer

David formerly served as the President & CEO of Sun-Rype Products. During his tenure at Sun-Rype, David achieved record net sales and EBITDA while taking Sun-Rype from a $13 million EBITDA loss to a $15 million EBITDA profit in his first year.  Previous to Sun-Rype, David served as the Senior VP of Marketing at Saputo Canada, where he oversaw the consumer marketing strategy for the largest division of the company.

David has successfully lobbied federal and provincial governments on regulatory and policy issues including working with BC Liquor Policy Review and the Liquor Control and Licensing Branch (LCLB) to modernize liquor regulations in BC. With some provinces already electing to control distribution and sales in the future adult-use market through their provincial liquor control board, David’s extensive background will be a tremendous asset in navigating through the complex and diverse federal and provincial regulations. His lengthy tenure with publicly traded companies on the TSX will be immensely beneficial in guiding GTEC’s future growth. David holds a Bachelor of Commerce (Marketing, Honours) and Master of Business Administration (Finance) from the University of British Columbia.

Kam Thindal


Kam is a Co-Founder and Managing Partner of Core Capital Partners (formerly Hamza Thindal Capital Corp., “Core”). Kam also currently serves as an advisor to Doventi Capital. Kam holds a Bachelor of Technology in Technology Management from the British Columbia Institute of Technology. Prior to forming Core, Kam spent five years as an independent capital markets advisor for several TSX-V listed companies. In 2014, Kam lead both the private funding and IPO financing for Canada’s fifth licensed cannabis producer, Thunderbird Pharma (currently known as Emerald Health Botanicals – EMH.V), simultaneously attracting capital investors while acquiring a control position.  Kam and his partners have funded and acquired both medicinal and recreational cannabis assets in Canada and the US.

For the past seven years Kam has sourced investments, negotiated financings and acquisitions in various sectors with a particular focus on biotech, health care, technology and special situations, including cannabis in both private and public companies.  Kam has funded several pre-clinical and clinical stage health care companies with an aggregate investment of over $50 million.

Joel Sherlock

VP of Business Development

Joel currently serves as the Co-Founder and Chief Executive Officer of Doventi Capital.  Joel brings a wealth of hands-on entrepreneurial business experience to the GTEC team. He is a graduate of the Harvard Business School Private Equity and Venture Capital Executive Program. With a background in finance, technology and real estate, he has been at the helm of multiple successful start-ups and corporate exits, including one of BC’s top private real estate brokerage houses, a national first action sports e-commerce company, a successful corporate consulting firm, and a $36 million private equity fund focused on real estate development in Arizona.

More recently, Joel has assisted in the placement of $22 million of investments into the legal cannabis sector. He also serves as the Chairman of the Board of Vitalis Extraction Technologies, the producer of an industry leading oil extraction system.

Jeremy Wright

Chief Financial Officer

Jeremy currently serves as the President & CEO of Seatrend Strategy Group. He has significant experience serving as a Director of Demetra Minerals, Budly Software, and Pacific Community Resources Society, and previously serving as a Director with PreveCeutical Medical, and the Canadian Freestyle Ski Association.  Additionally, Jeremy currently serves as the CFO for several public and private companies including: Centurion Minerals, Demetra Minerals, and Portofino Resources, and was previously the CFO for PreveCeutical Medical.

Jeremy is a Chartered Professional Accountant (Certified Management Accountant). He has extensive negotiation training, including the University of British Columbia’s Sauder School programs: “Advanced Negotiation Skills” and “Strategies, Skills and Tactics of Negotiation”. He also holds a Bachelor of Arts, with honours in Environmental Economics from Brock University.

David Buckle

Senior Operations Manager

David is the former Senior Grower at In The Zone (currently known as Original BC), a Licensed Producer under the ACMPR. David was responsible for: overseeing the junior growing team; developing a cultivation regiment that would ensure satisfaction to Health Canada’s QA/QC standards; overseeing harvests; and all over general cultivation duties.  David was integral to establishing the first three harvests for In The Zone, which played a pivotal role in them acquiring their Sales License from Health Canada. David also serves on the advisory board of Doventi Capital.

Matthew Fraser

Director of Retail Development

Matt is an entrepreneur and investor with extensive experience in the legal cannabis industry.  He is the founder of various cannabis-related businesses, including a medical cannabis clinic, a licensed cannabis dispensary, a cannabis extraction company, and a late stage Licensed Producer.   Matt’s Apollo Medical Cannabis Dispensary underwent a rigorous review process to become one of the few medical marijuana dispensaries to be granted a business license by the City of Vancouver.    Matt’s Solvent Zero cannabis extraction company is a leader in solvent-free cannabis extraction technology and manufactures the largest commercial Rosin Presses in the world.   These business initiatives have provided Matt with excellent knowledge and experience regarding the MMAR, MMPR and ACMPR medical cannabis regulations.

With his extensive background and knowledge in all aspects of the cannabis industry, Matt is an asset to the company’s growth, and its focus on vertical integration.  Mr. Fraser also has a strong real estate and finance background, and he is a graduate of the UBC Sauder School of Business.